acting dean of Medical School
President Richard C. Levin has named Dr. Dennis D. Spencer, the Harvey and Kate Cushing Professor of Neurosurgery and chair of neurosurgery, as acting dean of the School of Medicine.
Spencer, who has an international reputation in the surgical treatment of neurological diseases causing epilepsy, will serve as dean until a permanent dean is appointed to succeed Dr. David A. Kessler, who was named dean of the school of medicine at the University of California-San Francisco (UCSF).
"I wish to thank Dr. Spencer for agreeing to serve as acting dean while the search for a new dean is conducted," Levin said. "As a long-time faculty member and brilliant surgeon, he is well-respected among his colleagues and has a deep knowledge of the medical school. Under his leadership, the school will continue to pursue its ambitious plans for faculty recruitment and space renovation."
A graduate of Washington University School of Medicine, Spencer joined the Yale neurosurgery faculty after completing his residency at Yale in 1977. He became chief of neurosurgery in 1987 and chair of the department in 1997.
He developed a widely used surgical approach for patients with temporal lobe epilepsy and is a pioneer in stereotaxic cellular replacement therapy for patients with Parkinson's disease.
Spencer directs the surgical arm of the Yale Epilepsy Program, one of the most established centers in the world for the comprehensive treatment of patients with epilepsy. The interdisciplinary program brings together neurosurgery, neurology, neuropsychology, psychiatry, social workers, and neuroradiologists in a phased evaluation of patients who are diagnostic and/or therapeutic problems. The program successfully treats patients from around the world.
Spencer's research has brought together basic scientists and research clinicians around a National Institutes of Health (NIH) program project grant concerning the neurobiological study of human epileptogenic tissue. Study techniques include high field MR spectroscopy, intraoperative C13 glucose turnover studies, in vivo and in vitro electrophysiology and microdialysis, immunohistochemistry, confocal and EM microscopy, and molecular biology. Spencer has also interacted with the cellular transplant program directing the human investigational arm of fetal tissue transplantation for Parkinson's disease.
A member of many professional societies and boards, Spencer has received the American Epilepsy Society's clinical research award, chaired the American Board of Neurological Surgery and served on numerous medical school committees.
Kessler, the former commissioner of the U.S. Food and Drug Administration, was appointed dean of the Yale medical school in 1997 by Levin.
"David Kessler brought a unique array of talents and experience to the medical school," Levin said. "The school has made dramatic progress during his tenure and I speak for the entire University community in thanking him for his dedicated service and wishing him the best as he takes on an exciting new challenge."
A highlight of Kessler's deanship was the opening in May 2003 of a new $176 million research and teaching facility for the medical school at 300 Cedar Street in New Haven. The state-of-the-art facility, with space for 700 researchers, is part of a $500 million investment in medical school facilities and programs announced by Levin in February 2000.
T H I S
W E E K ' SS T O R I E S
Faculty win Blue Planet Prize; second Yale win in two years
Renowned neurosurgeon named acting dean of Medical School
High school students sample university life
City youths learn the fine art of playwriting
Changes in cloud elevation may affect Northeastern forests . . .
Students' winning house design parts with tradition
Summer music flourished under pianist's direction
MEDICAL SCHOOL NEWSBayer endows scholarship in biomedical research
Expert on Epstein-Barr virus gets MERIT Award
Research: Women who quit smoking more susceptible . . .
Study finds no racial gap in quality of care for heart patients
Study: Epilepsy patients especially prone to side-effects . . .
Antipsychotic drug may increase risk of diabetes
State-of-the-art center on Long Wharf will be home to . . .
Yale artist's painting wins award from National Academy of Art
Two faculty members elected into renowned society
Yale Glee Club has named its newest director
ASTRONOMICAL DISCOVERIESYale astrophysicists determine likely fate of . . .
Researcher touts 'Grand Unification' theory of galaxies
Astronomy fellow discovers new gravitational lens
Law professor Burke Marshall dies . . .
Thomas Greene, renowned literary scholar, dies at age 77
Leonard Kaplow dies; renowned pathologist
Symposium honors Shulman's work with NMR
Yale Books in Brief
Campus Notes
Bulletin Home|Visiting on Campus|Calendar of Events|In the News
Bulletin Board|Yale Scoreboard|Classified Ads|Search Archives|Deadlines
Bulletin Staff|Public Affairs Home|News Releases|
E-Mail Us|Yale Home Page